Use of modulators of the signal transduction pathway via the protein kinase Fyn for the treatment of tumor diseases

摘要

The present invention describes the use of modulators of the signal transduction pathway via the protein kinase Fyn (such as, for example, rho-kinase inhibitors or inhibitors of the protein kinase CSK) for the treatment of tumor diseases, in particular for the therapy of neuroblastoma.